Typhoid Vaccine Live Oral Ty21a (Vivotif)
Typhoid Vaccine Live Oral Ty21a is an FDA-licensed reference biologic from Bavarian Nordic A/S. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1989
Reference approved
Reference product
Vivotif Typhoid Vaccine Live Oral Ty21a
Bavarian Nordic A/S
- Approved
- Dec 15, 1989
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Typhoid Vaccine Live Oral Ty21a, in chronological order.
Reference approval
Approval date of the reference Typhoid Vaccine Live Oral Ty21a product.
37 yr ago
Frequently asked questions
Are there biosimilars approved for Typhoid Vaccine Live Oral Ty21a (Vivotif)?
No 351(k) biosimilars or interchangeable biosimilars referencing Typhoid Vaccine Live Oral Ty21a are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.